Evaluation of analytical and preliminary clinical performance of myconostica mycassay aspergillus when testing serum specimens for diagnosis of invasive aspergillosis

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2169-2174

  White, P Lewis ^a   Perry, Michael D ^a   Moody, Adrian ^b   Follett, Sarah A ^b   Morgan, Gillian ^b   Barnes, Rosemary A ^c  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b Myconostica Ltd   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; REAGENT;

ARTICLE; ASPERGILLUS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FUNGAL GENOME; HUMAN; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; MYCONOSTICA MYCASSAY ASPERGILLUS POLYMERASE CHAIN REACTION; NONHUMAN; PERFORMANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

ADULT; AGED; AGED, 80 AND OVER; ASPERGILLOSIS; ASPERGILLUS; CLINICAL LABORATORY TECHNIQUES; DNA, FUNGAL; HUMANS; MIDDLE AGED; MYCOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM;

ASPERGILLUS;

EID: 79957478237     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00101-11     Document Type: Article

References (24)

1. Barnes, R. A., et al. 2009. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J. Clin. Pathol. 62:64-69.
2. Bustin, S. A., et al. 2009. The MIQE guidelines: minimum information for the publication of quantitative real-time PCR experiments. Clin. Chem. 55:611-622.
3. Corless, C. E., et al. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39:1553-1558.
4. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
5. Donnelly, J. P. 2006. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin. Infect. Dis. 42:487-489.
6. Follett, S., R. O'Neill, and A. Moody. 2010. MycAssay Aspergillus: a CE marked real-time PCR assay for detecting Aspergillus DNA in respiratory samples, abstr. 117. Abstr. Advances Against Aspergillosis Conf.
7. Furuyama, A., S. Kanno, T. Kobayashi, and S. Hirano. 2009. Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch. Toxicol. 83:429-437.
8. Greene, R., K. Shibuya, and T. Ando. 2009. Histology and radiology, p. 353-362. In J.-P. Latge and W. J. Steinbach, ed., Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
9. Herrera, M. L., A. C. Vallor, J. A. Gelfond, T. F. Patterson, and B. L. Wickes. 2009. Strain-dependent variation in 18S ribosomal DNA copy numbers in Aspergillus fumigatus. J. Clin. Microbiol. 47:1325-1332.
10. Khot, P. D., D. L. Ko, R. C. Hackman, and D. N. Fredricks. 2008. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect. Dis. 8:73-86.
11. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
12. Leeflang, M. M., et al. 2008. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst. Rev. 4:CD007394.
13. Mengoli, C., M. Cruciani, R. A. Barnes, J. Loeffler, and J. P. Donnelly. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review of and meta-analysis. Lancet Infect. Dis. 9:89-96.
14. Mennink-Kersten, M. A., D. Ruegebrink, N. Wasei, W. J. Melchers, and P. E. Verweij. 2006. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 44:1711-1718.
15. Morton, C. O., et al. 2010. Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. J. Med. Microbiol. 59:408-413.
16. Myconostica Ltd. 2010. MycAssay™ Aspergillus Cepheid SmartCycler-serum. Instructions for use 080-045 version 1. Myconostica Ltd., Manchester, United Kingdom.
17. Pfeiffer, C. D., J. P. Fine, and N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427.
18. Verweij, P. E. 2009. Galactomannan and anti-Aspergillus antibody detection for the diagnosis of invasive aspergillosis, p. 363-372. In J.-P. Latge and W. J. Steinbach, ed., Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
19. Verweij, P. E. 2005. Advances in diagnostic testing. Med. Mycol. 43:S121-S124.
20. White, P. L., et al. 2010. The critical stages of extracting DNA from Aspergillus fumigatus in whole blood specimens. J. Clin. Microbiol. 48:3753-3755.
21. White, P. L., et al. 2010. Aspergillus PCR: one step closer towards standardization. J. Clin. Microbiol. 48:1231-1240.
22. White, P. L., and R. A. Barnes. 2009. Aspergillus PCR, p. 373-390. In J.-P. Latge and W. J. Steinbach, ed., Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
23. White, P. L., C. J. Linton, M. D. Perry, E. M. Johnson, and R. A. Barnes. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42:479-486.
24. Yamakami, Y., et al. 1998. Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J. Clin. Microbiol. 36:3619-3623.